{
  "id": 16287322,
  "title": "U.S. FDA issues four observations to Gland Pharma formulation facility near Hyderabad",
  "url": "https://urgent.news/2026/10/24/u-s-fda-issues-four-observations-to-gland-pharma-formulation-facility",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-24T05:38:23.000Z",
  "source": {
    "name": "The Hindu",
    "slug": "the-hindu",
    "url": "https://www.thehindu.com/business/Industry/us-fda-issues-four-observations-to-gland-pharma-formulation-facility-near-hyderabad/article71616791.ece"
  },
  "original_language": "en",
  "account": null,
  "summary": "The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}